Mohammadi-Khanaposhtani M - Search Results

1

Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles.

Mohammadi-Khanaposhtani M, Safavi M, Sabourian R, Mahdavi M, Pordeli M, Saeedi M, Ardestani SK, Foroumadi A, Shafiee A, Akbarzadeh T. Mohammadi-Khanaposhtani M, et al. Mol Divers. 2015 Nov;19(4):787-95. doi: 10.1007/s11030-015-9616-0. Epub 2015 Jul 14. Mol Divers. 2015. PMID: 26170096

2

Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.

Mohammadi-Khanaposhtani M, Saeedi M, Zafarghandi NS, Mahdavi M, Sabourian R, Razkenari EK, Alinezhad H, Khanavi M, Foroumadi A, Shafiee A, Akbarzadeh T. Mohammadi-Khanaposhtani M, et al. Eur J Med Chem. 2015 Mar 6;92:799-806. doi: 10.1016/j.ejmech.2015.01.044. Epub 2015 Jan 22. Eur J Med Chem. 2015. PMID: 25636055

3

Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.

Mohammadi-Khanaposhtani M, Mahdavi M, Saeedi M, Sabourian R, Safavi M, Khanavi M, Foroumadi A, Shafiee A, Akbarzadeh T. Mohammadi-Khanaposhtani M, et al. Chem Biol Drug Des. 2015 Dec;86(6):1425-32. doi: 10.1111/cbdd.12609. Epub 2015 Jul 20. Chem Biol Drug Des. 2015. PMID: 26077890

4

Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.

Arab S, Sadat-Ebrahimi SE, Mohammadi-Khanaposhtani M, Moradi A, Nadri H, Mahdavi M, Moghimi S, Asadi M, Firoozpour L, Pirali-Hamedani M, Shafiee A, Foroumadi A. Arab S, et al. Arch Pharm (Weinheim). 2015 Sep;348(9):643-9. doi: 10.1002/ardp.201500149. Epub 2015 Jul 20. Arch Pharm (Weinheim). 2015. PMID: 26192069

5

Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.

Mohammadi-Khanaposhtani M, Shabani M, Faizi M, Aghaei I, Jahani R, Sharafi Z, Shamsaei Zafarghandi N, Mahdavi M, Akbarzadeh T, Emami S, Shafiee A, Foroumadi A. Mohammadi-Khanaposhtani M, et al. Eur J Med Chem. 2016 Apr 13;112:91-98. doi: 10.1016/j.ejmech.2016.01.054. Epub 2016 Feb 1. Eur J Med Chem. 2016. PMID: 26890115

6

Design, synthesis, molecular modeling and anticholinesterase activity of benzylidene-benzofuran-3-ones containing cyclic amine side chain.

Mehrabi F, Pourshojaei Y, Moradi A, Sharifzadeh M, Khosravani L, Sabourian R, Rahmani-Nezhad S, Mohammadi-Khanaposhtani M, Mahdavi M, Asadipour A, Rahimi HR, Moghimi S, Foroumadi A. Mehrabi F, et al. Future Med Chem. 2017 May;9(7):659-671. doi: 10.4155/fmc-2016-0237. Epub 2017 May 9. Future Med Chem. 2017. PMID: 28485614

7

Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.

Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B. Nikookar H, et al. Bioorg Chem. 2018 Apr;77:280-286. doi: 10.1016/j.bioorg.2018.01.025. Epub 2018 Feb 3. Bioorg Chem. 2018. PMID: 29421703

8

Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.

Heydari Z, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Ranjbar PR, Larijani B. Heydari Z, et al. Med Chem. 2019;15(1):8-16. doi: 10.2174/1573406414666180528110104. Med Chem. 2019. PMID: 29807519 Review.

9

New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.

Adib M, Peytam F, Rahmanian-Jazi M, Mahernia S, Bijanzadeh HR, Jahani M, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Larijani B. Adib M, et al. Eur J Med Chem. 2018 Jul 15;155:353-363. doi: 10.1016/j.ejmech.2018.05.046. Epub 2018 May 29. Eur J Med Chem. 2018. PMID: 29902721

10

Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.

Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B. Mohammadi-Khanaposhtani M, et al. Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30. Bioorg Chem. 2018. PMID: 29980114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters